GlobalData on MSN1mon
Recordati to acquire worldwide rights to Sanofi’s antibody Enjaymo
Recordati has reached an agreement with Sanofi for acquiring the worldwide rights to Enjaymo, the only approved treatment ...
pharmaphorum11d
Sanofi claims FDA okay for drug to treat rare blood disorder CAD
Sanofi has won FDA approval for its sutimlimab ... The complement C1s-targeting antibody – given the brand name Enjaymo – has been cleared decrease the need for blood transfusions in patients ...
FiercePharma21d
Sanofi shrugs off potential RSV competition from Merck as Beyfortus grows sales 382%
In sustained rare disease push, Recordati lays out $825M upfront to acquire Sanofi's CAD drug Enjaymo Meanwhile, Sanofi saw revenues for its consumer health arm, Opella, grow 7.9%. Earlier this ...
Nasdaq21d
Sanofi Q3 Earnings Beat, Dupixent, New Drugs, Vaccines Drive Sales
New drug Enjaymo recorded sales of €28 million in the quarter compared with €26 million in the previous quarter. Sanofi has sold global rights to Enjaymo to Recordati. The transaction is ...